Royalty Pharma is looking to ensure its bid for Elan remains open even if some resolutions are passed by shareholders at EGM.  Photograph: Bryan O’Brien

Dublin-based fund Royalty Pharma has moved to fast-track its legal challenge to decisions by the Irish Takeover Panel that its $6.7 billion offer for (...)